Background Image
Table of Contents Table of Contents
Previous Page  41 / 48 Next Page
Information
Show Menu
Previous Page 41 / 48 Next Page
Page Background

SA JOURNAL OF DIABETES & VASCULAR DISEASE

RESEARCH ARTICLE

VOLUME 16 NUMBER 1 • JULY 2019

39

and suggests an association between raised total cholesterol

level and nucleoside reverse-transcriptase inhibitor (NRTI)-based

ART regimens in an HIV-infected African population. Our findings

provide further rationale for integrating routine cardiovascular risk-

factor screening into HIV-care services in resource-limited settings.

Larger studies with more detailed investigations and longer follow

up are recommended.

This work was supported by Grand Challenges Canada and

implemented in collaboration with ICAP Kenya, which implements

HIV PEPFAR care in the Nyanza region in Kenya.

References

1. Lewden C, Bouteloup V, de Wit SP, Sabin C, Mocroft A, Wasmuth JC,

et al

. All-

cause mortality in treated HIV-infected adults with CD4 500/mm3 compared with

the general population: evidence from a large European observational cohort

collaboration.

Int J Epidemiol

2012;

41

(2): 433–445.

2. Virginia AT, Hang L, Colleen H, Steven KG. Increased acute myocardial infarction

ratesandcardiovascularriskfactorsamongpatientswithhuman immunodeficiency

virus disease.

J Clin Endocrinol Metab

2007

92

(7): 2506–2512.

3. Glass TR, Ungsedhapand C, Wolbers M, Weber R, Vernazza PL, Rickenbach M,

et al

. Prevalence of risk factors for cardiovascular disease in HIV-infected patients

over time: the Swiss HIV Cohort Study.

HIV Med

2006;

7

(6): 404–410.

4. Islam FM, Wu J, Jansson J, Wilson DP. Relative risk of cardiovascular disease

among people living with HIV: a systematic review and metaanalysis.

HIV Med

2012;

13

(8): 453–468.

5. Armstrong C, Liu E, Grinspoon S, Okuma J, Spiegelman D, Guerino C,

et al

.

Dyslipidemia in an HIV-positive, antiretroviral treatment-naïve population in Dar

es Salaam, Tanzania.

J Acquired Immune Defic Syndr

2011;

57

(2): 141–145.

6. Bavinger C, Bendavid E, Niehaus K, Olshen RA, Olkin I, Sundaram V,

et al

. Risk

of cardiovascular disease from antiretroviral therapy for HIV: a systematic review.

PLoS One

2013;

8

(3): e59551.

7. Duprez DA, Neuhaus J, Kuller LH, Tracy R, Belloso W, De Wit S,

et al

. Inflammation,

coagulation and cardiovascular disease in HIV-infected individuals.

PLoS One

2012;

7

(9): e44454.

8. Prevention of recurrent heart attacks and strokes in low and middle income

populations. Evidence-based recommendations for policy makers and health

professionals. Geneva, 2003 World Health Organization. 2007.

9. Ministry of Health. National AIDS/STI Control Program (NASCOP).

Guidelines for

Antiretroviral Therapy in Kenya

. 4th edn. Nairobi, Kenya: 2011. Goverment of

Kenya, 2011.

10. Chobanian AV, Bakris GL, Black HR,

et al.

The seventh report of the Joint National

Committee on Prevention, Detection, Evaluation, and Treatment of High Blood

Pressure: JNC 7 report.

J Am Med Assoc

2003;

289

(19): 2560–2571.

11. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel

on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults

(Adult Treatment Panel III) final report.

Circulation

2002;

106

(25): 3143.

12. Joshi MD, Ayah R, Njau EK, Wanjiru R, Kayima JK, Njeru EK,

et al.

Prevalence

of hypertension and associated cardiovascular risk factors in an urban slum in

Nairobi, Kenya: A population-based survey.

BMC Public Health

2014;

14

: 1177.

13. Bloomfield GS, Hogan JW, Keter A, Sang E, Carter EJ, Velazquez EJ,

et al

.

Hypertension and obesity as cardiovascular risk factors among HIV seropositive

patients in western Kenya.

PLoS One

2011;

6

(7): e22288.

14. Temu TM, Kirui N, Wanjalla C, Ndungu AM, Kamano JH, Inui TS,

et al.

Cardiovascular health knowledge and preventive practices in people living with

HIV in Kenya.

BMC Infect Dis

2015;

15

: 421.

15. Abrahams-Gessel S, Denman CA, Gaziano TA, Levitt NS, Puoane T. Challenges

facing successful scaling up of effective screening for cardiovascular disease

by community health workers in Mexico and South Africa: policy implications.

Health Syst Policy Res

2015;

3

(1): 26.

16. Nordestgaard BRG, Langsted A, Mora S, Kolovou G, Baum Hr, Bruckert E,

et al

.

Fasting is not routinely required for determination of a lipid profile: clinical and

laboratory implications including flagging at desirable concentration cut-points:

a joint consensus statement from the European Atherosclerosis Society and

European Federation of Clinical Chemistry and Laboratory Medicine.

Eur Heart J

2016;

37

(25): 1944–1958.

Weight gain in early childhood increases heart and metabolic risk in adolescence

E

arlier onset of weight gain, under two years of age, is associated with

higher cholesterol, higher blood pressure, and more central fat in

adolescence, compared with onset of weight gain in children aged three to

five, finds a 14-year University of Sydney study.

The study tracked the body mass index (BMI) of children from birth to

14 years and found that earlier onset of high BMI (in children under two

years) resulted in higher cholesterol levels, higher blood pressure, and more

central (unhealthy) fat in adolescence, compared with onset of high BMI in

children aged three to five years.

Teenage obesity is a major health problem in Australia, but the

pathways to and the consequences of obesity in teenagers has not been

well studied. This is the first study to look at the consequences of weight

gain at two different stages of early childhood and its impact on developing

cardiovascular disease as an adult.

‘Our study found that there are two main pathways to obesity as a

teenager – rapid weight gain in the first two years of life (early weight gain)

or rapid weight gain between ages two and five years of age (later weight

gain),’ said senior author University of Sydney’s Professor David Celermajer,

Scandrett professor of cardiology at Sydney Medical School and the Heart

Research Institute.

‘The data show that there are consequences of the timing of the onset

of excess BMI in early childhood. Earlier onset of a rising BMI that persisted

through childhood results in greater central fat and higher cholesterol in

teenagers, independent of their BMI at 14 years.’

A group of 410 Australian children were assessed from birth throughout

childhood to age 14 years, recording their weight, height, and waist

circumference. Of the 410 children, 190 had detailed measurements of

cholesterol, blood pressure and central weight recorded at age 14 years.

Three groups were identified in the study: normal BMI, ‘early rising’ excess

BMI from two years, and ‘late rising’ excess BMI from five years.

Lead author Dr Jennifer Barraclough, cardiologist and PhD student

at University of Sydney and the Heart Research Institute said: ‘The early

weight-gain group have more centrally placed or unhealthy fat than

the later weight gain group. Fat around the middle is a key risk factor

for cardiovascular disease in adulthood. The early weight-gain group also

had significantly higher cholesterol levels compared to a group of healthy

weight teenagers.

‘Our study shows that the earlier the onset of excess fat before five

years of age, the more likely the individual is to have fat around the middle

by adolescence. The study also found that both early and late-weight gain

groups were more likely to have mothers with overweight or obesity and a

high BMI, than healthy weight teenagers.’

Co-author Professor Louise Baur, head of child adolescent health at the

University’s Sydney Medical School and The Children’s Hospital Westmead

said: ‘This study has shown that it is important for families and the

community to understand the risks of excess weight gain in early life and to

ensure healthy eating and activity are supported from a very young age.

‘These findings may provide an opportunity to identify “high risk” young

children and trial interventions at an early age, prior to the development

of high cholesterol and centrally placed fat, which becomes evident in

adolescence and increases the risk of heart disease as an adult.’

Baur highlighted the importance of healthy infant feeding.

‘Breastfeeding should be supported where possible until at least 12

months, with solids introduced from around six months. Healthy eating

and physical activity for all family members is also an important factor

promoting healthy weight gain in the young child. Family doctors and

early childhood nurses can also help to monitor weight gain in this critical

period of life,’ she said.

Source: Medical Brief 2019